Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$626M |
| 2 |
Warner Bros
WBD
|
+$447M |
| 3 |
Apple
AAPL
|
+$436M |
| 4 |
RTX Corp
RTX
|
+$434M |
| 5 |
Constellation Brands
STZ
|
+$320M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.13B |
| 2 |
Microsoft
MSFT
|
+$502M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$436M |
| 4 |
EXAS
Exact Sciences
EXAS
|
+$415M |
| 5 |
EA
Electronic Arts
EA
|
+$388M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.75% |
| 2 | Industrials | 9.36% |
| 3 | Consumer Discretionary | 8.52% |
| 4 | Healthcare | 7.75% |
| 5 | Financials | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
PUT
VanEck Junior Gold Miners ETF
GDXJ
$10B
| $3.6M | ﹤0.01% |
30,000
-30,000
| -50% | -$3.92M |
|
1452
CALL
JD.com
JD
$39.7B
| $3.59M | ﹤0.01% |
121,500
-694,700
| -85% | -$19.6M |
|
1453
CALL
Procter & Gamble
PG
$338B
| $3.58M | ﹤0.01% |
24,800
+6,000
| +32% | +$910K |
|
1454
Trinity Capital Inc
TRIN
$1.77B
| $3.57M | ﹤0.01% |
+242,655
| New | +$3.75M |
|
1455
Worthington Enterprises
WOR
$2.8B
| $3.57M | ﹤0.01% |
68,436
+49,200
| +256% | +$2.63M |
|
1456
Selective Insurance
SIGI
$5.47B
| $3.55M | ﹤0.01% |
+47,035
| New | +$3.85M |
|
1457
Zurn Elkay Water Solutions
ZWS
$8.1B
| $3.55M | ﹤0.01% |
79,076
+37,051
| +88% | +$1.77M |
|
1458
VICI Properties
VICI
$28.9B
| $3.53M | ﹤0.01% |
129,354
+78,318
| +153% | +$2.24M |
|
1459
PUT
S&P Global
SPGI
$128B
| $3.53M | ﹤0.01% |
8,300
+4,500
| +118% | +$2.09M |
|
1460
PUT
Southern Company
SO
$103B
| $3.52M | ﹤0.01% |
+36,500
| New | +$3.38M |
|
|
LAR
1461
Lithium Argentina AG
LAR
$1.1B
| $3.5M | ﹤0.01% |
524,270
-447,680
| -46% | -$3.2M |
|
1462
Medtronic
MDT
$117B
| $3.49M | ﹤0.01% |
40,328
-1,077,388
| -96% | -$103M |
|
1463
CALL
Agnico Eagle Mines
AEM
$113B
| $3.49M | ﹤0.01% |
+17,200
| New | +$3.58M |
|
1464
Advanced Energy
AEIS
$11B
| $3.48M | ﹤0.01% |
+10,781
| New | +$3.12M |
|
1465
Invesco Senior Income Trust
VVR
$453M
| $3.47M | ﹤0.01% |
1,076,638
+114,336
| +12% | +$367K |
|
1466
PUT
Ollie's Bargain Outlet
OLLI
$4.51B
| $3.45M | ﹤0.01% |
+37,500
| New | +$4.05M |
|
1467
CytomX Therapeutics
CTMX
$734M
| $3.43M | ﹤0.01% |
730,844
-3,141,358
| -81% | -$15.9M |
|
1468
Immunocore
IMCR
$1.93B
| $3.43M | ﹤0.01% |
+113,844
| New | +$3.68M |
|
1469
Iridium Communications
IRDM
$4.99B
| $3.43M | ﹤0.01% |
123,555
-67,003
| -35% | -$1.51M |
|
1470
CALL
Constellation Energy
CEG
$98.6B
| $3.41M | ﹤0.01% |
12,200
-26,700
| -69% | -$8.11M |
|
|
1471
CALL
Southern Company
SO
$103B
| $3.39M | ﹤0.01% |
35,100
+23,900
| +213% | +$2.21M |
|
1472
Hamilton Insurance Group
HG
$3.46B
| $3.39M | ﹤0.01% |
113,496
-358,653
| -76% | -$10.3M |
|
1473
Rallybio
RLYB
$89.7M
| $3.38M | ﹤0.01% |
+376,573
| New | +$2.57M |
|
1474
Oscar Health
OSCR
$9.55B
| $3.37M | ﹤0.01% |
294,171
-46,264
| -14% | -$652K |
|
1475
PUT
Blackstone
BX
$108B
| $3.36M | ﹤0.01% |
29,200
-90,800
| -76% | -$11.8M |
|
Similar funds
Dmitry Balyasny's Q1 2026 Portfolio in Review
As of Q1 2026, Dmitry Balyasny held 3,716 positions worth $77.1B, down 2.1% from $78.8B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Dmitry Balyasny withdrew a net $2.68B in Q1 2026, closing 911 positions and reducing 1,056 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $1.13B position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, down from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Dmitry Balyasny opened a new position in Silicon Laboratories worth $257M.
- Dmitry Balyasny's largest Q1 2026 buy was Silicon Laboratories: 1,233,893 shares worth $257M.
- Dmitry Balyasny added most to Meta Platforms (Facebook) in Q1 2026, an estimated $626M increase.
- Dmitry Balyasny's biggest Q1 2026 reduction was Microsoft, cutting an estimated $502M.
- Dmitry Balyasny fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $1.13B.
- Dmitry Balyasny's ten largest holdings make up 17% of its $77.1B portfolio in Q1 2026.
- Dmitry Balyasny opened 704 new positions and closed 911 in Q1 2026.
- Dmitry Balyasny's portfolio value fell 2.1% quarter-over-quarter to $77.1B.
Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.